Australia · Delayed Price · Currency is AUD Australian Clinical Labs Statistics
Total Valuation
ASX:ACL has a market cap or net worth of AUD 521.83 million. The enterprise value is 833.81 million.
| Market Cap | 521.83M |
| Enterprise Value | 833.81M |
Important Dates
The last earnings date was Monday, August 17, 2026.
| Earnings Date | Aug 17, 2026 |
| Ex-Dividend Date | Sep 2, 2026 |
Share Statistics
ASX:ACL has 185.05 million shares outstanding. The number of shares has decreased by -3.87% in one year.
| Current Share Class | 185.05M |
| Shares Outstanding | 185.05M |
| Shares Change (YoY) | -3.87% |
| Shares Change (QoQ) | -2.51% |
| Owned by Insiders (%) | 1.71% |
| Owned by Institutions (%) | 85.46% |
| Float | 171.76M |
Valuation Ratios
The trailing PE ratio is 22.87 and the forward PE ratio is 15.03. ASX:ACL's PEG ratio is 2.22.
| PE Ratio | 22.87 |
| Forward PE | 15.03 |
| PS Ratio | 0.71 |
| PB Ratio | 3.48 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.39 |
| P/OCF Ratio | 3.20 |
| PEG Ratio | 2.22 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.07, with an EV/FCF ratio of 5.42.
| EV / Earnings | 35.17 |
| EV / Sales | 1.13 |
| EV / EBITDA | 4.07 |
| EV / EBIT | 11.99 |
| EV / FCF | 5.42 |
Financial Position
The company has a current ratio of 0.54, with a Debt / Equity ratio of 2.25.
| Current Ratio | 0.54 |
| Quick Ratio | 0.44 |
| Debt / Equity | 2.25 |
| Debt / EBITDA | 1.65 |
| Debt / FCF | 2.19 |
| Interest Coverage | 4.74 |
Financial Efficiency
Return on equity (ROE) is 14.93% and return on invested capital (ROIC) is 9.68%.
| Return on Equity (ROE) | 14.93% |
| Return on Assets (ROA) | 7.45% |
| Return on Invested Capital (ROIC) | 9.68% |
| Return on Capital Employed (ROCE) | 18.17% |
| Weighted Average Cost of Capital (WACC) | 6.39% |
| Revenue Per Employee | 163,589 |
| Profits Per Employee | 5,269 |
| Employee Count | 4,500 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 30.49 |
Taxes
In the past 12 months, ASX:ACL has paid 13.38 million in taxes.
| Income Tax | 13.38M |
| Effective Tax Rate | 35.77% |
Stock Price Statistics
The stock price has increased by +5.62% in the last 52 weeks. The beta is 0.81, so ASX:ACL's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +5.62% |
| 50-Day Moving Average | 2.41 |
| 200-Day Moving Average | 2.35 |
| Relative Strength Index (RSI) | 64.35 |
| Average Volume (20 Days) | 1,035,964 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:ACL had revenue of AUD 736.15 million and earned 23.71 million in profits. Earnings per share was 0.12.
| Revenue | 736.15M |
| Gross Profit | 280.68M |
| Operating Income | 69.56M |
| Pretax Income | 37.39M |
| Net Income | 23.71M |
| EBITDA | 81.88M |
| EBIT | 69.56M |
| Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 25.66 million in cash and 337.41 million in debt, with a net cash position of -311.75 million or -1.68 per share.
| Cash & Cash Equivalents | 25.66M |
| Total Debt | 337.41M |
| Net Cash | -311.75M |
| Net Cash Per Share | -1.68 |
| Equity (Book Value) | 149.75M |
| Book Value Per Share | 0.81 |
| Working Capital | -96.94M |
Cash Flow
In the last 12 months, operating cash flow was 163.31 million and capital expenditures -9.58 million, giving a free cash flow of 153.73 million.
| Operating Cash Flow | 163.31M |
| Capital Expenditures | -9.58M |
| Depreciation & Amortization | 12.32M |
| Net Borrowing | -102.25M |
| Free Cash Flow | 153.73M |
| FCF Per Share | 0.83 |
Margins
Gross margin is 38.13%, with operating and profit margins of 9.45% and 3.22%.
| Gross Margin | 38.13% |
| Operating Margin | 9.45% |
| Pretax Margin | 5.08% |
| Profit Margin | 3.22% |
| EBITDA Margin | 11.12% |
| EBIT Margin | 9.45% |
| FCF Margin | 20.88% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 4.39%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 4.39% |
| Dividend Growth (YoY) | 4.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 105.43% |
| Buyback Yield | 3.87% |
| Shareholder Yield | 8.26% |
| Earnings Yield | 4.54% |
| FCF Yield | 29.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for ASX:ACL is 2.88, which is 2.13% higher than the current price. The consensus rating is "Hold".
| Price Target | 2.88 |
| Price Target Difference | 2.13% |
| Analyst Consensus | Hold |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 3.72% |
| EPS Growth Forecast (3Y) | 6.41% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:ACL has an Altman Z-Score of 2.15 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.15 |
| Piotroski F-Score | 5 |